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A B S T R A C T
Adipogenesis is a fundamental process of white adipose tissue function, supporting lipid storage and release,
while avoiding its spillover and ectopic accumulation in tissues and organs. During aging adipogenesis is im-
paired and among other factors, oxidative stress contributes to this process. Adipogenesis requires functional and
dynamic mitochondria; however, this organelle itself becomes dysfunctional during aging and accounts for most
of reactive oxygen species (ROS) production. Here, we evaluated whether oxidative stress impairs adipogenesis
through functional impairment of mitodynamics by utilizing hyperoxia as a continuous source of oxidative stress
while maintaining cellular viability. This negatively impacted mitochondrial function, including respiration and
dynamics and ultimately blocked adipogenesis. Interestingly, this state was reversible by using the antidiabetic
drug, Rosiglitazone, which reduced oxidative stress, restored mitochondrial dynamics and respiration and
augmented adipogenesis. Moreover, in vitro results were in agreement with in vivo models of oxidative stress and
aging, in which mice depleted of the superoxide dismutase enzyme 1 (SOD1) and old wild-type C57BL/6JRj mice
demonstrated the same trend of adipogenic potential. Importantly, in humans the results follow the same pat-
tern, showing a downregulation of adipogenic markers during aging. Since the levels of oxidative stress and
peripheral insulin resistance increase with age, while adipogenesis decreases during aging, our model helps to
understand a possible way to overcome physiologically low, steady stress conditions and restore adipogenesis,
avoiding accumulation of deleterious hypertrophic adipocytes in favor of beneficial hyperplasia.
1. Introduction
The white adipose tissue (WAT) is a key metabolic tissue, not only
important for regulating energy storage, but also by providing energy
for the organism upon demand. It is involved in regulating systemic
metabolism by secreting adipocyte-related hormones such as adipo-
nectin and leptin. Healthy adipose tissue relies on a continuous renewal
of its cells, so-called adipocytes. In the WAT, adipocytes differentiate
from multipotent mesenchymal stem cells (MSCs) in a multi-step
process called adipocyte differentiation or adipogenesis. The view that
continuous adipogenesis throughout life is detrimental is now outdated
[1]. Adipogenesis is crucial for organism metabolic homeostasis and its
diminishment represents a hallmark of obesity and insulin resistance
[2–4].
Diminished adipogenesis can contribute to hypertrophy of mature
adipocytes and eventually to free fatty acid release/spillover (lipo-
toxicity), resulting in insulin resistance across several tissues [5]. Fur-
thermore, adipocyte hypertrophy is associated with decreased lifespan
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[6]. In mouse models of impaired adipogenesis, metabolic complica-
tions such as lipodystrophy and insulin resistance are frequent [7,8].
During aging, a progressive functional decline of WAT and the
corresponding adipogenesis failure have been reported [1]. A likely
mechanistic cause of these effects is the chronic, low-level state of
oxidative stress (OS) observed during aging, which affects mitochon-
drial function and dynamics, contrary to acute, moderate oxidative
stress, which activates insulin signaling in adipocytes and improves it
function [9,10]. If this is true for preadipocytes, their capacity to dif-
ferentiate into mature adipocytes would be impaired [11,12]. Un-
raveling how aging, through oxidative stress, affects adipogenesis is of
utmost importance in order to avoid, delay or perhaps even treat me-
tabolic complications such as obesity and insulin resistance. A possible
cause for the gradual increase of chronic oxidative stress in adipose
tissue is mitochondrial dysfunction. Generally, mitochondria are con-
sidered to be closely connected to cellular ROS production, due to their
continuous action during metabolism and over time [13]. High ROS
levels produced by dysfunctional mitochondria have been suggested as
the main cause of aging [14], resulting from the accumulation of errors
impinged on biomolecules. Mitochondria are also crucial for adipo-
genesis as they are the main source of energy for differentiation, a
process which requires high levels of ATP [15,16]. Interestingly, the
aging process and adipose tissue dysfunction share similar features; for
example, obesity contributes to reduced lifespan, and the clinical out-
comes closely resemble those usually found in aged organisms [17].
Therefore, obesity might result from adipose tissue dysfunction via
functional impairment of mitochondria, ultimately causing excessive
ROS production and leakage. Various studies have shown the ad-
vantages of using hyperoxia as a model of inducing oxidative stress (O2
levels higher than 21% in cell culture) [18]. Hyperoxia is known to
dysregulate the mitochondrial respiratory chain through the reaction of
oxygen with electrons that leak from the electron transport chain, for
example from NADH or ubiquinone, which leads to the production of
superoxide anion radicals [13,18–20]. Therefore, we used hyperoxic
conditions as a chronic model to induce oxidative stress while main-
taining cellular viability.
In this study, we aim to understand how OS affects mitochondrial
function and adipogenesis. We found that under persistent non-toxic
oxidative stress (8 days under hyperoxia), mitochondrial dynamics
were impaired. This work is important by providing, for the first time,
the evidence that OS can directly impair the WAT adipogenic process
and that this might be an early mechanism of the development of me-
tabolic alterations. We were able to show that the non-toxic, chronic OS
could be overcome when treated with an antidiabetic drug, rosiglita-
zone. The PPARγ agonist rosiglitazone (R) ameliorated adipogenesis in
cells under OS conditions by improving mitochondrial biogenesis, dy-
namics and respiration. In spite of being the major ROS source, mi-
tochondria also display antioxidant defense mechanisms such as su-
peroxide dismutase. It has been shown that mice lacking Cu/Zn-
superoxide dismutase display increased levels of oxidative stress in
several tissues and plasma [21], mostly related with higher levels of
mitochondrial ROS, and decreased ATP levels and oxygen consumption
[22]. Cu/Zn-superoxide dismutase-deficient mice also exhibit ac-
celerated sarcopenia and decreased lifespan [23]. The early mortality of
this mouse model seems to be associated with hepatocarcinogenesis in
comparison to the wild type C57BL6 control mice [24]. Therefore, we
took advantage of this oxidative stress mouse model and investigated
whether the epididymal WAT (eWAT) of these animals had similar
trends in expression of adipogenic and mitochondrial genes to our in
vitro oxidative stress model. Taking advantage of the GTEx dataset, we
could show that during human aging some of the main adipogenesis
drivers are downregulated, both in men and women, in subcutaneous
white adipose tissue, possibly reflecting a loss of adipogenic potential.
2. Material and methods
2.1. Experimental animals
Male C57BL/6JRj mice were purchased from Janvier Labs (France),
at 16 and 105 weeks of age (8 and 7 mice, respectively) and kept in
agreement with our laboratory animals guidelines for one week until
sacrifice. Mice were euthanized with isoflurane followed by cardiac
puncture. The eWAT was collected, frozen in liquid nitrogen and stored
at -80 °C until processed. All experimental procedures were performed
in accordance with the guidelines of German Law on the Protection of
Animals and were approved by the local authorities (Landesamt für
Umwelt, Gesundheit und Verbraucherschutz, Brandenburg, Germany).
Sod1 knockout (Sod1−/−) mice were originally generated at the
University of Texas Health Science Center at San Antonio (UTHSCSA)
and the Oklahoma Medical Research Foundation (OMRF). Mice were
shipped to the Biomedical Services Unit, University of Liverpool. At
both sites, mice were maintained under barrier conditions in micro-
isolator cages on a 12 h dark/light cycle and were fed a CRM (P) rodent
diet. Mice were euthanized by cervical dislocation, and eWAT was ra-
pidly removed, frozen in liquid nitrogen, and stored at −80 °C.
Procedures were performed in accordance with UK Home Office
guidelines under the UK Animals (Scientific Procedures) Act 1986 and
received ethical approval from the University of Liverpool Animal
Welfare Ethical Review Body (AWERB).
2.2. 3T3-L1 cell culture and differentiation
3T3-L1 preadipocytes were grown to confluency in DMEM (4.5 g/L
glucose, 2 mM glutamine) (Thermo Fischer Scientific) supplemented
with 10% FCS (Merck) (Normal Medium, NM). Five days later, adipo-
genesis was induced by incubation with DMEM containing 10% FCS,
170 nM bovine insulin (Sigma Aldrich), 1 μM dexamethasone (Sigma
Aldrich) and 0.5 mM 3-Isobutyl-1-methylxanthine (IBMX, Sigma
Aldrich) (Differentiation Medium, DM). After 2 days, the medium was
replaced to NM supplemented with insulin for the remaining days
(Maintaining Medium, MM). Cells were then allowed to differentiate for
6 more days in MM. For oxidative stress induction, cells were placed in
hyperoxia (40% O2) or treated with antimycin A (Sigma Aldrich) for 5
days (20 nM) during DM and MM.
2.3. Oil Red O staining
To measure intracellular lipid content, cells were firstly washed in
Phosphate Buffer Saline (PBS). Afterwards, they were fixed in for-
maldehyde 4% for 20 min. After fixation, cells were washed and in-
cubated with Oil Red O dye (Sigma Aldrich) (3:2 isopropanol/H2O). To
completely remove unspecific dye binding, cells were repeatedly wa-
shed in H2O for three times and allowed to air dry for 30 min. After
drying, lipids were solubilized in DMSO (Sigma Aldrich) and the ab-
sorbance was read at 519 nm on a plate reader.
2.4. Measurement of ROS levels
Cells were incubated for 1 h in 3 μM H2DCFDA (diluted in NM).
Afterwards, the media was carefully removed and cells were lysed in
DMSO. Absorbance was read in the dark at 504/519 nm (emission/
excitation. The obtained values were normalized to the cell number.
2.5. Isolation of RNA and real-time RT-PCR analysis from 3T3-L1 cells
Total RNA was extracted from 3T3 cells using the RNeasy Mini Kit
(Qiagen, Hilden, Germany). From each sample, 1 μg of RNA was tran-
scribed into cDNA with SuperScript II reverse transcriptase (Invitrogen)
and poly (dT)15 primers. Expression of mRNA was analyzed by real-
time RT-PCR using the Mx3005P system (Stratagene). PCR was
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performed with 10 ng cDNA, iQ SybrGreen Supermix (Biorad) and 0.5
μM of specific primers. Primers were designed using the Universal
Probe-Library Assay Design Center (Roche) or from Harvard
Primerbank. Mouse ribosomal protein, large, P0 (Rplp0) was used as
internal normalization control. Primer sequences are referred to in
Supplemental Table 1.
2.6. Isolation of RNA and real-time RT-PCR analysis from eWAT
mRNA was extracted from 30 mg of eWAT using Dynabeads™mRNA
purification kit (Thermo Fisher Scientific, Darmstat, Germany) ac-
cording to manufacturer's guidelines. From each sample, 100 ng mRNA
were transcribed with SensiFAST cDNA Synthesis kit (Bioline, London,
UK). RT-PCR reactions were performed with Dream-Taq-Hot Start-DNA
polymerase (Thermo Fisher Scientific, Darmstadt, Germany) and SYBR
Green (Invitrogen, Carlsbad, USA). Ribosomal genes L13a, Rpl13a, and
actin were used as internal normalization controls. The primer se-
quences used are the same as referred above.
2.7. Immunoblotting
Cells were lysed in lysis buffer, containing 0.1% Triton-100X, NaCl,
EDTA and Tris pH 7.4 supplemented with phosphatase inhibitors.
Protein concentration was determined using Bradford reagent.
10–15 μg of protein were separated by SDS-PAGE and transferred onto
nitrocellulose membranes. For protein carbonylation assay, the pro-
tocol was followed according to Ref. [25]. Next, membranes were in-
cubated with primary antibodies (Supplemental Table 2) overnight at
4 °C followed by incubation for 1 h at room temperature with fluor-
escent labeled secondary antibodies (Supplemental Table 2). Im-
munodetection was performed by Odyssey® (Li-Cor Biosciences).
2.8. Mitochondrial isolation
Cells were trypsinized (trypsin/EDTA) and centrifuged at 1200 rpm
for 3 min, media was discarded and cells were resuspended 0.5 ml
Fractionation Buffer (250 mM Sucrose, 10 mM Tris pH 7.5, 1 mM
EDTA). Afterwards, cell were pottered 6x at 1000 rpm (on ice), cen-
trifuged at 1000 g for 10min (4 °C) to remove unbroken cells.
Supernatants were then centrifuged at 17000 g for 15 min (4 °C)
(pellet = Mitochondria; supernatant = cytosolic fraction). Pellets were
resuspended in 100 μl (Resuspension Buffer 250 mM Sucrose, 10 mM
MOPS-KOH, 80 mM KCl, 5 mM MgCl2-Solution) and stored at -80 °C.
Protein concentration was measured with Pierce 660 nm protein assay
(ThermoFisher Scientific).
2.9. mtDNA content
DNA extraction from cells was performed using the Invisorb® Spin
Tissue Mini Kit (Stratec) according to the protocol supplied by the
manufacturer. DNA was amplified with specific primers using a SYBR
green PCR Master Mix (Promega). The analysis was performed using
ViiA 7 Real-Time PCR system (Applied Biosystems). Mitochondrial DNA
content of mitochondrial-encoded genes, including NADH-ubiquinone
oxidoreductase chain 1 (ND1), NADH-ubiquinone oxidoreductase 6
(ND6) and cytochrome c oxidase subunit 2 (COX2), were compared
with a representative nuclear gene – Choline dehydrogenase (Chdh1).
The primer sequences are found in Supplemental Table 1.
2.10. HPLC ATP/ADP levels
2.10.1. Sample preparation
After counting, 1 million cells were used from each condition.
Cellular pellets were resuspended in 500 μl H2O and boiled for 10 min
and cooled on ice for 10 min. Next, the samples were centrifuged for
10 min at 12000 rpm. Afterwards, the supernatants were filtered
(Waters Syringe Filters 0.2 μm) and 1 μl of each sample supernatant was
determined by HPLC. This was conducted in a Agilent 1290 Infinity LC
system under the following specifications; the column ZORBAX RRHD
SB-Aq 2.1x50mm, 1.8 μM (Agilent) + UHPLC Guard 3 PK ZORBAX-SB-
Aq 2.1x5 mm 1.8-μm (Agilent), solvent A (10 mM NH4H2PO4) and
2 mM PIC reagent A + 18% acetonitrile. For solvent B acetonitrile was
used. The flow-rate was 0.2 ml/min, isocratic 99:1 and UV 254 nm. ATP
and ADP concentration levels presented in μM were achieved after
performing a calibration curve with standard ATP and ADP con-
centrations.
2.11. Mitochondrial dynamics
Cells were incubated in HBSS (Hank's Balanced Salt Solution with
calcium and magnesium without phenol red, Gibco®) with 100 nM of
Mitotracker Red (Thermofisher Scientific). After 30 min, cells were
washed and placed in HBSS for mitochondrial dynamics visualization in
a Zeiss confocal microscope LSM780, prepared with an atmosphere-
chamber (temperature- and gas-control, 37 °C and 5% CO2, respec-
tively). Analysis was done using ZEN standard software.
2.12. Seahorse assay
The Seahorse XF96 extracellular flux analyzer was used to monitor
mitochondrial respiration, where oxygen consumption rate (OCR) was
measured using Seahorse XF mito stress kit. This consisted of injecting
sequentially the final concentrations of 2 μM oligomycin in order to
inhibit ATP synthase, 1 μM carbonyl cyanide-4 (trifluoromethoxy)
phenylhydrazone (FCCP) to uncouple oxygen consumption from ATP
production and 0.5 μM Rotenone/Antimycin to inhibit complex I and
III, respectively. The day prior to the assay, 7000 cells/well were seeded
in a 96 well microplate in 100 μl medium. For background signal, four
wells were left without cells. On the day of the experiment, the loaded
sensor cartridge was calibrated and the cells were washed and replaced
with Dulbecco's Modified Eagle's medium (Sigma-Aldrich) supple-
mented with 1 mM sodium pyruvate, 2 mM glutamine and 10 mM
glucose. The cells were then incubated for 45 min at 37 °C in a non-CO2
incubator. After calibration, the microplate was placed into the sea-
horse analyzer. The Wave 2.4.0 software was used to analyze the data.
Data was normalized to total protein amount and OCR was calculated
by pmol/min/μg protein.
2.13. Antibody micro-array
3-4 millions cells (from T125 flasks), were trypsinized, washed and
centrifuged. Then, 5 μl of protease inhibitor cocktail was added to each
cellular pellet and stored at -80 °C. Pellets were then shipped to
Sciomics for protein assessment. A volcano plot was used to display the
differently expressed proteins from “control 8 days” and “oxidative
stress 8 days” conditions. Data acquisition and analysis slide scanning
was conducted using a Powerscanner (Tecan, Austria) with identical
instrument laser power and adjusted PMT settings. Spot segmentation
was performed with GenePix Pro 6.0 (Molecular Devices, Union City,
CA, USA). Acquired raw data were analyzed using the linear models for
microarray data (LIMMA) package of R-Bioconductor after uploading
the median signal intensities. For normalization, a specialized invariant
Lowess method was applied. Duplicate spots were averaged prior to the
comparison of different experimental conditions. For analysis of the
samples a one-factorial linear model was fitted with LIMMA resulting in
a two-sided t-test or F-test based on moderated statistics.
2.14. Immunohistochemistry
eWAT was isolated, fixed in paraformaldehyde 4% and embedded in
paraffin. Cross sections were cut using a microtome. The sections were
first de-paraffinized by re-hydration in Roti-Histol (Carl Roth,
R. Fernando, et al. Redox Biology 32 (2020) 101507
3
Karlsruhe, Germany) and washed in decreasing serial dilutions of
ethanol. For antigen retrieval, the slides were placed in citrate buffer
(10 mM citrate acid and 0.05% Tween 20 in distilled water) at 95 °C for
20 min. Slides were cooled down for another 20 min at room tem-
perature. Slides were incubated in a dark humified chamber for 1 h
with blocking buffer containing 10% goat serum in antibody diluent
(DAKO, Carpinteria, CA, USA). Slides were then incubated with anti-
Pref-1/DLK1 primary antibody (R&D systems, Minneapolis, USA)
overnight at 4 °C. Secondary antibody Alexa-fluor donkey anti-goat™
546 IgG (Thermofisher Scientific) was then used for 1 h at room tem-
perature. The sections were mounted with Roti-mount FluorCare DAPI
(Carl Roth, Karlsruhe, Germany).
2.15. Statistical analysis
All figures and statistical analyses were performed using GraphPad
Prism 6 software. Data represent in average three to four independent
experiments (N = 3–4) and is presented as mean ± SEM. Statistical
differences were considered when p ≤ 0.05 using the unpaired
Student's t-test for the comparison within 2 groups or one-way ANOVA
when more than 2 groups were compared.
2.16. GTEx analyses
We downloaded GTEx v7 from dbGap [26], and analyzed RNAseq
quantifications in the adipose tissue, subdivided in two subtissues:
subcutaneous (sWAT) and visceral (vWAT). We examined genes in-
volved in adipogenesis, and tested the correlation between age and
gene expression level separately for each subtissue and for female and
males. P-values from Pearson's correlation tests were corrected by FDR
considering the full list of genes examined. The R programming lan-
guage was used for statistical tests and plots.
3. Results
3.1. (Pre)adipocytes under hyperoxia-induced oxidative stress do not show
increased levels of adipogenesis
Several studies have used hyperoxia as an oxidative stress inducer,
mimicking chronic conditions during aging [27,28]. We established
hyperoxic conditions (40% O2) for preadipocyte cultures as a con-
tinuous source of oxidative stress. These conditions suppressed 3T3-L1
cell differentiation after 8 days, as evidenced by Oil Red O staining
(Fig. 1A), while avoiding loss of cell number (Fig. 1B). Mechanistically,
hyperoxic conditions reduced the mRNA levels of adipogenesis tran-
scription factors such as Pparγ and Cebpα as well as Plin1, an adipogenic
marker (Fig. 1C).
3.2. Hyperoxia leads to increased oxidative stress
As expected, intracellular ROS levels were higher in oxidative
stressed cells, and carbonylated proteins (a marker for oxidative da-
mage) were also increased, confirming that our model indeed promotes
oxidative stress (Fig. 1D and E, respectively). Moreover, by employing
an antibody array, we found that many upregulated proteins in oxi-
dative stress conditions are annotated with gene ontology (GO) terms
related to response to stress and aging, reinforcing the idea that our
hyperoxia model mimics oxidative stress (Supplemental Fig. 1). Re-
markably, oxidative stressed cells could differentiate after a recovery
period of 8 days in normal conditions (21% O2), suggesting that the
model represents reversible oxidative stress. This was also consistent
with the raise in lipid accumulation (Supplemental Figs. 2A) and a
decline in carbonylated proteins (Supplemental Fig. 2B) after allowing
the cells to recover in normal conditions for a further 8 days post stress.
These results support the idea that metabolic dysfunction mediated by
oxidative stress can be overcome under these conditions.
3.3. Oxidative stress does not affect gene expression in mitodynamics but is
sufficient to induce mitochondrial dysfunction
Considering that mitochondria are important for both ROS pro-
duction and adipogenesis, we decided to evaluate the effect of hyper-
oxia on mitochondrial function. Therefore, we characterized mi-
tochondria according to levels of mitochondrial protein complexes; ATP
levels; mitochondrial DNA copy as an indicator of mitochondrial mass;
mitochondrial dynamics and biogenesis; and mitochondrial movement.
In order to assess a possible shift between mitochondrial proteins, such
as mitochondrial electron transport chain complexes, we first isolated
mitochondria and performed Western blot analysis against five subunits
of the electron transport chain. This analysis revealed reduced levels in
some of the respiratory chain complexes when comparing oxidative
stressed cells (non-differentiating) and controls (differentiating) cells
(Fig. 2A). There is a clear downregulation of the complexes I and II. The
reduction of these complexes and the loss in stoichiometry likely ac-
counts for reduced respiration and mitochondrial dynamics [29,30].
Since mtDNA copy number is an indicator of mitochondrial mass [31],
we determined mitochondrial content by analyzing the ratio of mi-
tochondrial (Nd1, Nd6, Cox2) to genomic DNA content (Chdh1)
(Fig. 2B). The results indicate a decline in Nd1 and Cox2 genes, sug-
gesting a reduced mitochondrial content in cells exposed to hyperoxia.
Due to the lower mitochondrial content and expression of ETC com-
plexes, the ATP levels of control and OS-treated cells were investigated.
The ATP/ADP ratio slightly decreased in OS treated cells yet did not
reach statistical significance (Fig. 2C), which could explain the im-
pairment in adipogenesis. We also tested whether oxidative stress is
detrimental to mitochondrial dynamics and biogenesis. For this, we
evaluated several proteins responsible for mitodynamics and genes such
as mitofusin 2 (Mfn2), mitochondrial fission 1 (Fis1) and dynamin re-
lated protein 1 (Drp1), as well as the peroxisome proliferator activated
receptor gamma coactivator 1 alpha (Pgc1α), as a marker of mi-
tochondrial biogenesis (Supplemental Figs. 3A–D, respectively). The
levels of the outer mitochondrial membrane protein critical for mi-
tochondrial fusion, Mfn2, were significantly lower in oxidative stressed
cells. Moreover, the levels of mitochondrial fission protein Fis1, as well
as the mitochondrial dynamin-related protein Drp1, were found to be
lower, although not significantly, in oxidative stressed cells. This sug-
gest an impairment of mitochondrial dynamics. The mitochondrial
biogenesis transcription coactivator, PGC1α, also exhibited a tendency
for lower protein levels in oxidative stressed cells (Supplemental
Fig. 3D), corroborating the idea of reduced mitochondrial content.
However, qPCR data for the respective mitochondrial dynamics and
biogenesis genes did not show differences when comparing control and
oxidative stress conditions (Supplemental Fig. 3F). This suggests that
mitochondrial dysregulation is more likely to be caused by oxidative
stress modifications rather than by altered transcriptional regulation, at
least those related to mitochondrial dynamics. Mitochondria are active
organelles that require mobility in order to carry out their cellular
functions. Mitochondria are important for cell growth and differentia-
tion, calcium signaling and regulation of the cell cycle [32,33].
Therefore, we set to assess whether oxidative stress affects mitochon-
drial mobility, employing a live cell mitochondrial-targeted dye. The
stained mitochondria in cells were then acquired by imaging every 5 s,
which was compiled in the form of a video. The results showed that
oxidative stressed cells display an increase in mitochondrial rigidity
(less movement), less fusion and more of a fission-like state compared
with control cells (Supplemental Fig. 3E). Considering the evaluation of
several mitochondrial parameters, such as mitochondrial function,
content and dynamics, and the fact that mitochondria were affected by
oxidative stress, we assessed another important factor, the mitochon-
drial respiration capacity. This was analyzed using a Seahorse XF96
assay. Sequential injections of different modulator compounds that
target complexes of the electron transport chain were performed. The
measurement started with the mitochondrial oxygen consumption rate
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(OCR) in resting conditions (basal respiration), in which differences
were not observed between control or oxidative stressed cells. After
injecting oligomycin, OCR decreased in both conditions. This suggests
the amount of O2 consumed by the proton leak did not differ between
control and oxidative stress conditions. Next, FCCP increased the OCR
to its maximal respiratory capacity (maximal respiration), which was
significantly lower in OS cells. Finally, a mixture of rotenone and an-
timycin A was injected, inhibiting CI and CIII and concomitantly
blocking mitochondrial respiration, which did not differ between con-
ditions. In conclusion, basal respiration levels did not differ between
control and stressed cells, however, maximal respiration capacity was
significantly lower in the OS cells (Fig. 2D), which may account for the
observed loss of adipogenic capacity. These data support the view that
the ATP/ADP ratio is not significantly affected by oxidative stress in
these cells, as ATP production is not altered (calculated from oligo-
mycin treatment), however we did observe a decrease in the ATP/ADP
ratio, when measured by HPLC, yet it did not reach statistical sig-
nificance (p=0.058). One explanation for this disparity might be dif-
ferences in ATP turnover by OS cells. In fact, these changes in ATP
turnover rates have been documented in mouse lung cells subjected to
hyperoxia [34]. Another possible explanation could account for the
higher usage of ATP in OS cells to maintain viability. This would in-
clude processes such as DNA repair, stress protein synthesis or home-
ostasis of ions levels.
Taken together, these results show that oxidative stress resulting
from hyperoxia strongly induces mitochondrial structural rearrange-
ments, leading to increased ROS generation and contributing to the
impediment of adipocyte differentiation.
3.4. Rosiglitazone significantly improves adipogenesis in oxidative stressed
cells
As mentioned before, Pparγ is a master regulator of adipogenesis.
Since we verified its reduction under stress conditions, we decided to
boost its activity by subjecting 3T3-L1 cells to the common anti-diabetic
drug and agonist, rosiglitazone (R) [35]. We verified a significant in-
crease in lipid droplet formation compared to non-R treated hyperoxic
cells (Fig. 3A). Remarkably, there was an increase of the mitobiogenesis
transcriptional coactivator marker, PGC1α, at protein level (Fig. 3A), as
well as an increase fusion (Mfn2) and fission (DRP1) proteins
(Supplemental Figs. 4A and B, respectively), suggesting an improve-
ment of mitochondrial content and dynamics. Moreover, we observed
by live-cell imaging that mitochondria were morphologically different
in cells subjected to oxidative stress (Supplemental Fig. 3E-video
available in online version). It could be clearly noted that the move-
ment of stressed cells treated with R was restored, and the fission-like
state now shifted towards a more fusion-like state, indicating an im-
provement of mitodynamics [36]. Interestingly, this corresponded to an
increased mRNA expression of adipogenic markers (Fig. 3B) and a trend
for reduced protein carbonylation, indicating a possible reduction in
Fig. 1. Oxidative stress impairs adipogenesis in 3T3 cells.
The terms “C” and “OS” represent control (black column) and oxidative stress (grey column) and each condition is quantified relative to control. (A) The graphic
depicts Oil Red O staining quantification of control and oxidative stressed cells, after 8 days differentiation. On the right, the upper panel represents the control
(differentiated) cells and bellow the oxidative stress (non-differentiated) cells. The data from oxidative stressed cells were always normalized to the control (n = 9).
(B) Graphic represents cell number of control and OS cells after 8 days differentiation. (C) mRNA expression of Plin1, Fabp4, C/ebpα and Pparγ under normoxia (C)
and hyperoxia (OS) conditions. Rplp0 was used as housekeeping gene. (D) ROS levels in C and OS cells. The values are expressed in percentage and each condition is
normalized to cell number, and where OS is relative to C. (E) Densiometric quantification of carbonylated proteins (n = 3). Statistical significance was given as
follows *p < 0.05, **p < 0.01, ***p < 0.001 (unpaired t-test) Values are presented as mean ± SEM.
R. Fernando, et al. Redox Biology 32 (2020) 101507
5
oxidative stress or to increased turnover of carbonylated proteins
(Fig. 3C). The mitochondrial electron transport chain proteins remained
mostly unchanged, but with an increased but non-significant response
to R treatment for complexes I, II and IV (Fig. 3D). Furthermore, mi-
tochondrial biogenesis (Pgc1α) and dynamic-related genes (Fis1, Mfn2
and Opa1) were elevated (Fig. 3E). Interestingly, not only the maximal
but also the basal respiratory capacity was significantly increased
(Fig. 3F), suggesting a recuperation of the oxidative phosphorylation
machinery and its function.
3.5. Impairment of adipogenesis is a result of mitochondrial malfunction
In order to prove that mitochondrial function is crucial for adipo-
genesis, we treated cells with mitochondrial inhibitors under normoxic
conditions and assessed the capacity for differentiation. We treated
3T3-L1 cells under normoxic conditions with a non-toxic concentration
(20 nM) of mitochondrial complex III inhibitor, antimycin A (AA), for 8
days. A notable decrease in adipogenesis could be seen by the Oil Red O
staining test (Fig. 4A). Furthermore, a reduction in movement of the
mitochondrial network was observed upon live-cell imaging (Fig. 4B-
video available in online version). As mitochondrial movement is de-
pendent on tubulin microtubules, we tested if blocking microtubule
polymerization and depolymerization cycles affects mitochondrial
movement and henceforth contributes to a reduction of adipogenesis.
For this, we treated cells with nocodazole. To avoid interfering with
mitotic clonal expansion that occurs during the initial two days after
placing cells in the differentiation cocktail, we only treated cells after
this event had taken place. As expected, after 8 days, adipogenesis was
diminished (Fig. 4C). In agreement with our findings, Woods et al. [37],
demonstrated that microtubules are essential for mitochondrial fission
and fusion and the disruption of its dynamics is linked with decreased
metabolic function, increased ROS production and impairment of ATP
generation. Thus, these two different approaches triggering mitochon-
drial dysfunction could be one of the reasons for the failure of the
Fig. 2. Hyperoxia affects mitochondrial expression and function.
The terms “C” and “OS” represent the control (black column) and oxidative stress (grey column) and each condition is relative to the control. (A) Densiometric
quantification of each electron transport chain complex in C and OS cells, relative to control. On the right, a representative western blot is observed as well as the
Ponceau S staining, used as a loading control. (B) The graphic represents mitochondrial DNA content relative to a nuclear gene – ChDh1. (C) The graphic represents
the ATP/ADP ratio measured by HPLC. The samples are normalized to the same cell number and OS is relative to C. Graphic bars result from three to four
independent experiments. (D) Representative analysis of mitochondrial basal and maximal respiration of C and OS cells after 8 days differentiation. The graphic on
the left represents the quantification of the oxygen consumption rate (OCR) of the basal and maximal respiration in pmol/min/μg of protein. The graphic on the right
represents the schematic profile of mitochondrial respiration parameters over time (in minutes) of both control and oxidative stress (n = 14). Statistical significance
was given as follows *p < 0.05, **p < 0.01, (unpaired t-test). Values presented as mean ± SEM.
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adipogenic program.
3.6. Impairment of the adipogenic potential in an in vivo SOD1 KO model
We further evaluated the eWAT in an in vivo oxidative stress model -
mice lacking the Cu/Zn-superoxide enzyme (Sod1 KO). These mice were
shown to display oxidative stress and accelerated aging. The body
weight of these animals was slightly reduced when compared with Wt
animals, although this did not reach statistical significance (Fig. 5A), as
previously shown [24]. In addition, adipogenic genes had a lower ex-
pression in Sod1 KO mice (Fig. 5B). Although there was increased high
variability in Fabp4 levels, all the other genes related to adipogenesis
exhibited a trend for decreased expression, especially the master reg-
ulator of adipogenesis, Pparγ, and the mitochondrial biogenesis tran-
scription factor, Pgc1α (Fig. 5C). This agrees with our in vitro model
demonstrating the role of oxidative stress in the impairment of adipo-
genesis. Chronic oxidative stress and dysregulation of gene expression
are important features of aged tissues. To investigate whether oxidative
stress and aging shared the same pattern in gene expression, we con-
tinuously passaged 3T3-L1 preadipocytes (41 passages). Aged cells
showed impaired adipogenesis, as observed by Oil Red O quantification
(Fig. 5D), in which lipid droplets were reduced in the higher passages.
This coincided with a significant downregulation in the expression of
genes related to adipogenesis and mitodynamics (Fig. 5E and F, re-
spectively). Similar features were observed in vivo, between the eWAT
of young and old mice, despite not reaching statistical significance
(Fig. 6). Furthermore, the preadipocyte factor 1 (Pref1), a marker of
preadipocytes known to inhibit adipogenesis [38], was found higher in
old eWAT tissue, yet not significant, suggesting lower adipogenesis
during aging could lead to a higher accumulation of precursor cells,
preadipocytes (Fig. 6A). In addition, adipogenic and mitodynamic
genes previously assessed in cells, showed a similar trend in old tissues
(Fig. 6B). It is important to mention that in tissues, the gene expression
signals might be diluted due to the presence of other cell types.
Nevertheless, these results agree with the genotype-tissue expression
(GTEx) dataset [26], wherein adipogenic markers in sWAT such as
PPARG, CEBPA, PLIN1 and FABP4, were progressively downregulated
during aging in humans (Fig. 7).
Fig. 3. Rosiglitazone rescues adipogenesis by increasing mitochondrial biogenesis, respiration and dynamics.
The terms “OS” and “Rosi” always represent the oxidative stress (grey column) and rosiglitazone (dark grey column), and each condition is relative to the control
(despite not being shown). (A) The graphic represents the Oil Red O staining of OS cells and OS cells treated with Rosi. On the upper right is the picture of OS, and
bellow is the picture of the cells treated with Rosi. Bellow the figures there is a representative western blot of PGC1α and the respective Ponceau S used as a loading
control (n = 3). (B) The plot displays mRNA expression levels of Plin1, Fabp4, C/ebpα and Pparγ under hyperoxia and hyperoxia treated with Rosi. Rplp0 served as
housekeeping gene (n = 3). (C) The graphic represents densiometric quantification of carbonylated proteins. (D) Densiometric quantification of each electron
transport chain complex relative to control. On the right, a representative western blot is observed as well as the Ponceau S staining, used as a loading control
(n = 4). (E) The graphic represents mRNA expression levels of mitochondrial dynamics genes such as Drp1, Fis1, Mfn2 and Opa1 as well as mitochondrial biogenesis
Pgc1α of OS cells and OS cells treated with Rosi. Rplp0 served as housekeeping gene and the data is relative to the control (n = 3). (F) The graphic on the left
represents the quantification of the oxygen consumption rate (OCR) of the basal and maximal respiration in pmol/min/μg of protein. The graphic on the right
represents the schematic profile of mitochondrial respiration parameters over time (in minutes) of both OS and OS+Rosi (n = 14). Statistical significance was given
as follows *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 (unpaired t-test). Values presented as mean ± SEM.
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4. Discussion
Adipogenesis is a physiological process wherein preadipocytes un-
dergo growth arrest, differentiate and accumulate lipids as mature
adipocytes, preventing ectopic lipid deposition in peripheral tissues.
However, when impaired it can lead to severe consequences such as
obesity and insulin resistance. The aging process seems to be re-
sponsible for the functional decline of many tissues, including the WAT
and therefore its renewal capacity. Oxidative stress is considered to play
an important role in the aging process. Mitochondria are crucial for cell
energy supply, as they are the main source of ATP, generated via the
energy released from oxidation of nutrients. Adipogenesis is a tightly
controlled process involving many proteins; among them is Pparγ,
known as the master regulator. The expression of Pparγ is induced in a
positive feedback loop by Cebpα [39]. These two important transcrip-
tion factors are responsible for the activation of adipose-specific gene
expression enhancers and thus maintain the adipogenesis transcrip-
tional program [40]. Together, they are involved in cellular processes
such as proliferation and differentiation [15]. Mitochondria are con-
sidered to be, at least in some tissues, the major site for ROS production,
which can actually be important for the initiation of Pparγ transcrip-
tional machinery by means of redox signaling [15,41]. However, when
the physiological levels of ROS increase above a certain threshold, tis-
sues face oxidative stress [42]. Here, we demonstrate that adipogenesis
is impaired by oxidative stress and aging, and that this is mediated by
mitochondrial dysfunction. Interestingly, we also show that these con-
ditions can be reversed by pharmacological approaches such as treating
cells under stress with PPARγ agonists. These observations shed light on
chronic hyperoxia-related oxidative stress models of inhibiting adipo-
genesis, demonstrated by the inability of preadipocytes to differentiate
into mature adipocytes (Fig. 1A). Mechanistically, this was shown by
the decreased mRNA levels of Cebpα and Pparγ. Moreover, other adi-
pogenic markers such as Plin1 and Fabp4 were lowly expressed in cells
exposed to hyperoxia, demonstrated by the absence of lipid droplets.
As expected, in cells exposed to hyperoxia, we observed higher le-
vels of ROS and carbonylated proteins (Fig. 1D and E).
As an irreversible non-enzymatic modification, carbonylation is a
marker of severe oxidation of proteins and therefore a reliable marker
of oxidative stress. Metabolic dysfunction represented by type 2 dia-
betes is characterized by elevated ROS levels and oxidative stress [5].
Surprisingly, the amount of carbonylated proteins was decreased when
the cells were exposed to a recovery period of eight more days under
normoxia conditions, after being exposed for eight days to hyperoxia
(Supplemental Fig. 2B). This may be explained by protein turnover
through the proteasome when normoxia is restored [43,44] and by the
dilution effect of cellular division. Interestingly, under these conditions,
adipogenesis was also recovered (Supplemental Fig. 2A).
As already mentioned above, mitochondrial dysfunction can lead to
oxidative stress, due to increased ROS production. In our model, this
appears to follow a similar mechanism to oxidative phosphorylation
complexes; specifically, we observed a downregulation of mitochon-
drial complex I and II (Fig. 2A), which probably has an impact on
maximal but not basal respiration. Consistent with this observation,
there was a close to significant (p = 0.058) decrease in ATP content
(Fig. 2C), suggesting altered ATP consumption by the oxidative stressed
cells, in which ATP production was not changed (Fig. 2D). A decline in
mitochondrial DNA copy number was also observed (Fig. 2B). This
finding is expected, since it is known that mitochondrial DNA is
abundant during preadipocyte differentiation, and in our oxidative
stress model the differentiation process was impaired [15]. Interest-
ingly, cells under hyperoxia showed a lower maximal respiration ca-
pacity, presumably as a consequence of the reduction in complex I and
II levels.
After demonstrating how oxidative stress can disrupt adipogenesis,
we tested whether a recovery in adipogenesis would be achievable
using the antidiabetic drug, rosiglitazone. This drug is an agonist of
Pparγ, which plays a key role in adipogenesis, as supported by several
reports showing its beneficial effects in different diseases with impaired
mitochondria [35,45,46]. This was also true in our hyperoxia treated
cells, where we could show that R counteracts the negative effects of
oxidative stress. In fact, rosiglitazone treatment of cells exposed to
hyperoxia could recover adipogenesis (Fig. 3A). This effect could also
be a consequence of enhanced mitochondrial biogenesis, seen by the
increase of PGC1α (Fig. 3A). This was also evidenced by an upregula-
tion of mitochondrial fusion and fission machinery, observed by live-
cell imaging (Supplemental Fig. 4A, B and C, respectively), reflecting
higher mitochondrial dynamic. Rosiglitazone also rescued mRNA levels
of adipogenic markers and mitochondrial fusion-fission machinery
(Fig. 3B and E, respectively). Since rosiglitazone is an agonist of Pparγ,
it seems to directly activate transcription and thus the metabolic pro-
gram during adipogenesis. Increased fission machinery could also ex-
plain the lower amount of carbonylated proteins (Fig. 3C), since fission
Fig. 4. Mitochondrial inhibitors impair adipogenesis.
(A) The graphic represents the comparison between C (black), OS (light grey) and 5 days treatment of 20 nM Antimycin A (A.A.) (dark grey). Each condition is
relative to control. (B) The upper panel shows a representative video of mitochondria under 8 days normoxia conditions and the lower panel shows mitochondria
under 8 days normoxia conditions treated with A.A. for 5 days. These videos can be seen in the online version (mitochondria stained with mitotracker). (C) The
graphic represents Oil Red O staining of cells under normoxia conditions (black column) and cells under normoxia conditions treated with 100 nM nocodazole (Ndz)
for 2 days (n = 3). Statistical significance was given as follows ***p < 0.001 (One-Way ANOVA) and p < 0.0001, (unpaired t-test). Values presented as
mean ± SEM.
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dilutes the accumulation of DNA mutations and oxidized proteins [47].
However despite this, the difference in levels of oxidative phosphor-
ylation complexes between control and oxidative stressed cells did not
reach statistical significance – rosiglitazone seemed to restore complex
I, II and IV protein levels. Regarding mitochondrial respiration, we were
able to show differences between control and oxidative stressed cells.
We observed that in addition to an increase in maximal respiration,
basal respiration was also increased. To verify the extent by which
mitochondrial function is crucial for adipogenesis, we also tested for
cells under normoxia treated with antimycin A, an inhibitor of mi-
tochondria complex III (cytochrome c oxidoreductase), resulting in ROS
production [48]. After treatment, we showed the same tendency for
lower adipogenesis capacity as seen in hyperoxia-treated cells, con-
firming that mitochondria are crucial for adipogenesis (Supplemental
Fig. 4A and B). Another important factor for mitochondrial function is
motility. Mitochondria are dynamic organelles that move along mi-
crotubules inside the cell, a process which is crucial to their function.
Under hyperoxia conditions, we showed impairment in mitochondrial
mobility and function. Adding to this, the reduction of mitochondrial
dynamic by the microtubule inhibitor nocodazole achieved a similar
level of adipogenesis reduction (Fig. 4C). We observed that adipogen-
esis declined after 8 days of nocodazole treatment, reinforcing the im-
portance of mitochondria motility and dynamics.
As we demonstrated that “unhealthy” mitochondria lead to im-
paired adipogenesis in 3T3-L1 cells, either by hyperoxia or with use of
mitochondrial function/dynamics inhibitors, we examined whether our
findings are transferable to an in vivo situation. We took advantage of an
in vivo mouse model lacking an important mitochondrial and cyto-
plasmic antioxidant enzyme, superoxide dismutase 1 (SOD1), which is
prone to increased levels of oxidative stress. Indeed, Vasilaki et al. [49]
have shown that these mice display higher levels of protein carbonyls
and 3-nitrotyrosine, two markers of oxidative damage. We collected the
eWAT from these mice. As we analyzed the whole tissue and not just
individual preadipocytes, we focused mainly on the important adipo-
genic transcription factors, Cebpα and Pparγ (Fig. 5B), and the master
regulator of mitochondrial biogenesis, Pgc1α (Fig. 5C). Probing for
these specific genes allowed us to assess a type of “adipogenic poten-
tial”, since we could not examine the cells of interest individually.
Fig. 5. Adipogenesis is impaired in a mouse model of oxidative stress and accelerated aging.
(A) Body weight in grams of Wild type (WT) (black column) and CuZnSOD1KO (SOD1KO) (grey column). (B) and (C) mRNA levels of adipogenesis and mitobio-
genesis markers, respectively, in epididymal white adipose tissue from 8 month-old WT and CuZnSOD1 KO mice. For each qPCR, 4 mice from each group were used.
(D) Oil Red O staining quantification in different cell passages. The right panels represent the adipogenesis state of each cell passage. (E) and (F) Adipogenesis and
mitodynamics markers in young and old cell passages, respectively (n = 3). Statistical significance was given as follows *p < 0.05, (unpaired t-test). Values
presented as mean ± SEM.
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These markers tended to be decreased in mice lacking superoxide dis-
mutase, supporting our studies in vitro.
These results suggest that oxidative stress plays a detrimental role in
adipogenesis.
Oxidative stress accumulates with aging and therefore one would
expect decreased adipogenesis in aged eWAT. In fact, when staining
eWAT tissue for Pref1, a preadipocyte marker, we observed a trend for
increased Pref1 in old eWAT, suggesting that the old mice may have
more preadipocytes, and thus less adipogenic capacity compared to
young animals (Fig. 6A). With regard to adipogenesis, mitodynamics
and antioxidant markers, these were slightly reduced in the old tissue,
suggesting an adipogenic impairment during aging (Fig. 6B). This ap-
pears to have the same effect in human subjects. Taking advantage of
the GTEx dataset, we found that the expression of 4 analyzed genes
(PPRAG, CEBPA, PLIN4 and FABP4) was significantly reduced with age.
This effect was more pronounced in subcutaneous fat tissue than in
visceral fat. The human data helps to elucidate why in our mouse
epididymal adipose tissue we observe trends, but not significant
changes, during aging. Our data suggest that different WAT should be
carefully and independently studied, as it is known that subcutaneous
adipose tissue has higher basal levels of adipogenic genes, such as Pparγ
and Cebpα [50], pointing to different regulation and metabolism in
these types of adipose tissue.
In conclusion, our results emphasize that functional and dynamic
mitochondria are crucial for the adipocyte differentiation process. This
was demonstrated not only in vitro, but also in the analyzed mice
models and in humans. However, despite being used for diabetes type II
treatment, it remains unclear whether rosiglitazone could restore the
adipogenesis process during aging. Additional studies are needed to
demonstrate its efficacy in the treatment of obesity and aging.
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